Automated urinary output-measuring systems and methods

Information

  • Patent Grant
  • 12364423
  • Patent Number
    12,364,423
  • Date Filed
    Monday, December 20, 2021
    3 years ago
  • Date Issued
    Tuesday, July 22, 2025
    3 days ago
Abstract
Disclosed are automated urinary output (“UO”)-measuring systems and methods. An automated UO-measuring system can include a container configured to collect a fluid such as urine. The container can include a console, one or more ultrasonic sensors coupled to the console for determining a fluid level within the container, one or more accelerometers coupled to the console for determining a near-zero acceleration state of the container for the determining of the fluid level within the container, and a valve configured to pass fluid therethrough by way of a fluid line coupled to the valve. The automated UO-measuring system can also include a container holder. The container holder can have a pocket for holding the container and a sleeve for securing the container to a user. A method of the automated UO-measuring system can include a method of using the automated UO-measuring system to collect and measure urine output of the user.
Description
BACKGROUND

Low urinary output in those with congestive heart failure (“CHF”) can be a symptom of low cardiac output. It can be difficult to non-invasively measure urinary output in those with CHF as they are often ambulatory, and most automated urinary output measuring devices are invasive and engineered for the intensive care unit and non-ambulatory patients. It would be beneficial to CHF patients and clinicians to be able to measure urinary output accurately and automatically in ambulatory CHF patients.


Disclosed herein are automated urinary output (“UO”)-measuring systems and methods that address the foregoing.


SUMMARY

Disclosed herein is an automated UO-measuring system including a container configured to collect fluid, the container having a console, one or more ultrasonic sensors coupled to the console, one or more accelerometers coupled to the console, and a valve configured to pass fluid therethrough. The system also includes a fluid line coupled to the valve and a container holder. The container holder has a sleeve configured to be secured to a user and a pocket configured to securely hold the container.


In some embodiments, the console, the one-or-more ultrasonic sensors, the one-or-more accelerometers, and the valve are organized into a panel.


In some embodiments, the panel divides the container into a proximal section or a distal section.


In some embodiments, the panel is located at a proximal end or a distal end of the container.


In some embodiments, the panel includes a pump configured to create a low-pressure environment inside the container.


In some embodiments, the console includes one of more processors, a non-transitory storage medium, an energy source and one or more logic modules.


In some embodiments, the one-or-more logic modules are configured to receive accelerometer values from the one-or-more accelerometers, determine an acceleration state of the container, activate the one-or-more ultrasonic sensors, receive ultrasonic sensor values from the one-or-more ultrasonic sensors, correlate the ultrasonic sensor values with a volume-of-voided-urine value within the container and a time-of-day value for a correlation, determine a volume of urine using the ultrasonic sensor values, activate a pump to create and maintain a low-pressure environment inside the container, transmit the correlation to a computing device, or a combination thereof.


In some embodiments, the one-or-more logic modules are configured to activate the one-or-more ultrasonic sensors occurs when the acceleration state of the container is below a threshold.


In some embodiments, the container holder is configured to be detachably secured to the user.


In some embodiments, the sleeve includes two or more arms configured to wrap around an appendage of the user.


In some embodiments, the two-or-more arms are organized into a first pair of fastening arms and a first pair of securing arms.


In some embodiments, the container holder is secured to the appendage of the user by hook-and-loop fasteners or magnets.


In some embodiments, the sleeve includes a compression sock configured to be slidably secured to an appendage of the user.


In some embodiments, the container includes a rigid container.


Also disclosed herein is a method of automatically measuring urine output including capturing a volume of voided urine from a user, in a container using a fluid line, the container being coupled to the user, distal a bladder of the user, the container having a valve configured to pass fluid therethrough and a console coupled to one or more ultrasonic sensors and one or more accelerometers. The method also includes detecting an acceleration state of the container, measuring the volume of voided urine over time in the container, correlating the measured volume of voided urine with a volume value and a time-of-day value, and transmitting the volume value and the time-of-day value to a computing device.


In some embodiments, capturing the volume of voided urine from the user includes maintaining a low-pressure environment in the container with a pump of the container.


In some embodiments, detecting the acceleration state of the container includes using the one-or-more accelerometers to detect the acceleration state of the container.


In some embodiments, measuring the volume of voided urine over time in the container includes measuring the volume when the acceleration state of the container is zero.


In some embodiments, measuring the volume of voided urine over time in the container includes using the one-or-more ultrasonic sensors to measure the volume of voided urine over time.


In some embodiments, measuring the volume of voided urine over time in the container includes both measuring and recording at evenly spaced time intervals.


In some embodiments, the time intervals are user-defined.


In some embodiments, transmitting the volume value and the time-of-day value to the computing device includes wirelessly transmitting the volume value and the time-of-day value to the computing device.


These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which describe particular embodiments of such concepts in greater detail.





DRAWINGS

A more particular description of the automated UO-measuring systems and methods will be rendered by reference to specific embodiments thereof that are illustrated in the drawings. It is appreciated that these drawings depict only some embodiments of the foregoing and are, therefore, not to be considered limiting to the scope of the concepts provided herein. Example embodiments will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1A illustrates a perspective view of an automated UO-measuring system in accordance with some embodiments.



FIG. 1B illustrates a perspective view of the automated UO-measuring system in accordance with some embodiments.



FIG. 1C illustrates a side view of a container of the automated UO-measuring system in accordance with some embodiments.



FIG. 2 illustrates a block diagram of some components of the automated UO-measuring system in accordance with some embodiments.



FIG. 3A illustrates a method of measuring urinary output in accordance with some embodiments



FIG. 3B illustrates another method of measuring urinary output in accordance with some embodiments.



FIG. 4A illustrates a container holder of the automated UO-measuring system in a ready-to-use state in accordance with some embodiments.



FIG. 4B illustrates the container holder of FIG. 4A in use in accordance with some embodiments.



FIG. 5A illustrates a side view of another container holder of the automated UO-measuring system in use in accordance with some embodiments.



FIG. 5B illustrates a front view of the container holder of FIG. 5A in use in accordance with some embodiments.



FIG. 6 illustrates a flow chart of a method of measuring urinary output using the automated UO-measuring system in accordance with some embodiments.





DESCRIPTION

Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.


Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.


With respect to “proximal,” a “proximal portion” or a “proximal-end portion” of, for example, a container disclosed herein includes a portion of the container intended to be near a clinician when the container is used on a user. Likewise, a “proximal length” of, for example, the container includes a length of the container intended to be near the clinician when the container is used on the user. A “proximal end” of, for example, the container includes an end of the container intended to be near the clinician when the container is used on the user. The proximal portion, the proximal-end portion, or the proximal length of the container can include the proximal end of the container; however, the proximal portion, the proximal-end portion, or the proximal length of the container need not include the proximal end of the container. That is, unless context suggests otherwise, the proximal portion, the proximal-end portion, or the proximal length of the container is not a terminal portion or terminal length of the container.


With respect to “distal,” a “distal portion” or a “distal-end portion” of, for example, a container disclosed herein includes a portion of the container intended to be near or in a user when the container is used on the user. Likewise, a “distal length” of, for example, the container includes a length of the container intended to be near or in the user when the container is used on the user. A “distal end” of, for example, the container includes an end of the container intended to be near or in the user when the container is used on the user. The distal portion, the distal-end portion, or the distal length of the container can include the distal end of the container; however, the distal portion, the distal-end portion, or the distal length of the container need not include the distal end of the container. That is, unless context suggests otherwise, the distal portion, the distal-end portion, or the distal length of the container is not a terminal portion or terminal length of the container.


Alternatively, logic can be software, such as executable code in the form of an executable application, an Application Programming Interface (API), a subroutine, a function, a procedure, an applet, a servlet, a routine, source code, object code, a shared library/dynamic load library, or one or more instructions. The software can be stored in any type of a suitable non-transitory storage medium, or transitory storage medium (e.g., electrical, optical, acoustical or other form of propagated signals such as carrier waves, infrared signals, or digital signals). Examples of non-transitory storage medium can include, but are not limited or restricted to a programmable circuit; semiconductor memory; non-persistent storage such as volatile memory (e.g., any type of random access memory “RAM”); or persistent storage such as non-volatile memory (e.g., read-only memory “ROM,” power-backed RAM, flash memory, phase-change memory, etc.), a solid-state drive, hard disk drive, an optical disc drive, or a portable memory device. As firmware, the executable code can be stored in persistent storage.


The term “computing device” should be construed as electronics with the data processing capability and/or a capability of connecting to any type of network, such as a public network (e.g., Internet), a private network (e.g., a wireless data telecommunication network, a local area network “LAN,” etc.), or a combination of networks. Examples of a computing device can include, but are not limited or restricted to, the following: a server, an endpoint device (e.g., a laptop, a smartphone, a tablet, a “wearable” device such as a smart watch, augmented or virtual reality viewer, or the like, a desktop computer, a netbook, a medical device, or any general-purpose or special-purpose, user-controlled electronic device), a mainframe, internet server, a router; or the like.


A “message” generally refers to information transmitted in one or more electrical signals that collectively represent electrically stored data in a prescribed format. Each message can be in the form of one or more packets, frames, HTTP-based transmissions, or any other series of bits having the prescribed format.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.



FIG. 1A illustrates a perspective view of an automated UO-measuring system 100 in accordance with some embodiments. In some embodiments, the automated UO-measuring system 100 includes a container 110 configured to receive and contain a volume of voided urine generated by a user or patient. In some embodiments, the container 110 can be a rigid container, which includes a container length 116, a container depth 118 and is configured to contain a volume of fluid therein. As used herein, a rigid container means a container that is stiff and unyielding as opposed to pliant or flexible. In some embodiments, the container 110 is clear, for visual determination of the fluid volume therein. The container 110 can be configured to have various shapes including a triangular prism, a rectangular prism, a pentagonal prism, an irregular prism, a cylinder, a polyhedron or the like. In some embodiments, the container 110 has a fixed three-dimensional structure. In an embodiment, the container 110 includes a cavity configured to fit the container 110 flush against a user's appendage 152. In some embodiments, the container 110 can be constructed of a hardened polymer such polycarbonate, polyethylene, polypropylene, polystyrene or the like.


In some embodiments, the container 110 includes a valve 126 on a proximal end 112 of the container 110. In some embodiments, the valve 126 can include a directional valve, a check valve, umbrella valve, flapper valve or the like. In some embodiments, the valve 126 can be configured to be removed, to dispose of the volume of voided urine in the container 110. In some embodiments, a fluid line 156 from the user configured to transport voided urine therein, can be distally coupled to the valve 126 of the container 110. In some embodiments, the fluid line 156 can include a hollow tubing constructing of a clear plastic polymer such as polycarbonate, polyethylene terephthalate, polystyrene, urethane, nylon or the like. In some embodiments, the fluid line 156 can be coupled to a urine collection device, wherein the urine collection device is configured to capture a volume of voided urine from the user's bladder 154 and the fluid line 156 is configured to channel the urine to the container 110 through the valve 126. The container 110 is configured to be secured to a user, distal of the user's bladder 154 in order to allow fluid flow to the container 110 through passive gravity flow. For example, in some embodiments, the container 110 can be secured to a thigh, a calf or an ankle.



FIG. 1B illustrates a perspective view of the automated UO-measuring system 100 in accordance with some embodiments. In some embodiments, the container 110 includes the valve 126, one or more accelerometers 122, one or more ultrasonic sensors 124 and a console 130. In some embodiments, the valve 126, the one-or-more accelerometers 122, the one-or-more ultrasonic sensors 124 and the console 130 can be organized into a panel 120. In some embodiments, the panel 120 can be proximally located or distally located on the container 110. The one-or-more accelerometers 122 can be configured to detect when the container 110 is accelerating or not such that the fluid level within the container 110 can be determined when the container 110 is not accelerating. The one-or-more ultrasonic sensors 124 can be configured to detect the fluid level within the container 110 that will be described in more detail herein. The console 130 can be configured to receive accelerometer values from the one-or-more accelerometers 122, receive detected ultrasonic measurements from the one-or-more ultrasonic sensors 124 and transmit the measured or determined values in a message to a computing device that will be described in more detail herein. In some embodiments, the computing device can include a computing device, a smartphone, a medical device, a laptop or the like.


In some embodiments, the panel 120 can be configured to divide the container 110 into a proximal section 111 and a distal section 113. The container 110 can be configured to detachably separate at the panel 120, into the proximal section 111 and the distal section 113, and can be configured to be rejoined into one piece through a press fit, a snap fit, an interference fit or the like. In some embodiments, the container 110 can be configured to detachably separate to dispose of the volume of voided urine. In some embodiments, the panel 120 can be secured within the proximal section 111. In some embodiments, the fluid line 156 can be detached from the valve 126 to dispose of the volume of voided urine through the valve 126.



FIG. 1C illustrates a side view of the container 110 including the panel 120 of the automated UO-measuring system 100 in accordance with some embodiments. In some embodiments, the panel 120 includes a pump 128 configured to evacuate air from the container 110 to create a low-pressure environment inside the container 110 to assist urine drainage into the container 110. In some embodiments, the pump 128 is coupled to the console 130 and controlled by the console 130. In some embodiments, the pump 128 can be configured to be activated after the volume of voided urine within the container 110 has be disposed. In some embodiments, the pump 128 includes a pressure sensor configured to detect the pressure within the container 110 in order to maintain a consistent low-pressure environment in the container 110.



FIG. 2 illustrates a block diagram of some components of the automated UO-measuring system 100 in accordance with some embodiments. In some embodiments, the automated UO-measuring system 100 includes the console 130. In some embodiments, the console 130 can be contained within the panel 120 or coupled separately to the container 110. The console 130 includes one or more processors 132, non-transitory storage medium (“memory”) 134, an energy source 135 and one or more logic modules such as a plurality of logic modules. In some embodiments, the energy source 135 can be configured to provide energy to the one-or-more accelerometers 122, the one-or-more ultrasonic sensors 124, the pump 128, and the console 130. In some embodiments, the console 130 can be configured to detect data and transmit the detected data to a computing device for processing. In some embodiments, the one-or-more logic modules are selected from an accelerometer value-receiving logic 136, an acceleration state-determining logic 138, an ultrasonic sensor-activating logic 140, an ultrasonic sensor-receiving logic 142, a volume determination logic 144, a pump control logic 146, and a communications logic 148. In some embodiments, the memory 134 can include a data store such as an ultrasonic-sensor data store 150. The accelerometer value-receiving logic 136 can be configured to receive measured accelerometer values from the one-or-more accelerometers 122. In some embodiments, the acceleration state-determining logic 138 can be configured to determine an acceleration state of the container 110 based on the measured accelerometer values. In some embodiments, the acceleration state-determining logic 138 can determine the acceleration state of the container 110 by determining if the accelerometer values are above or below a near-zero threshold accelerometer value. In some embodiments, the ultrasonic sensor-activating logic 140 can be configured to activate the one-or-more ultrasonic sensors 124. In some embodiments, the ultrasonic sensor-activating logic 140 can be configured to activate the one-or-more ultrasonic sensors 124 only when the console 130 determines the container 110 has an acceleration state that is about zero, for example, by way of comparison to the near-zero threshold accelerometer value. In some embodiments, the ultrasonic sensor-receiving logic 142 can be configured to receive a measured time value of the time it takes an ultrasonic wave generated by the one-or-more ultrasonic sensors 124 to be detected after reflection inside the container 110, that will be described in more detail herein.


In some embodiments, the volume determination logic 144 can be configured to determine the volume of voided urine contained within the container 110 by correlating the measured time value of the reflected ultrasonic wave with a volume value corresponding to the volume of voided urine within the container 110. In some embodiments, the volume determination logic 144 can be further configured to associate a time-of-day value with each the volume value at the time of day the volume value was determined. In some embodiments, the volume determination logic 144 can be configured to generate an associated pairing of the {time-of-day value, volume value}. In some embodiments, the volume determination logic 144 can be configured to associate other parameters with the associated pairing in an associated trio, an associated quartet, an associated quintet, and an associated sextet or the like. For example, the volume determination logic 144 can associate a device-operating-condition value, a voided number in a user-defined timer-period value, a device-status value or the like. In some embodiments, the pump control logic 146 can be configured to activate the pump 128 to create the low-pressure environment within the container 110. In some embodiments, the pump control logic 146 can be configured to activate the pump 128 to maintain the low-pressure environment within the container 110. In an embodiment, the pump 128 includes the pressure sensor configured to detect the pressure within the container 110 and acquire pressure readings within the container 110. In this embodiment, the pressure sensor can transmit the pressure readings to the console 130 and the pump control logic 146 can be configured to activate the pump 128 to maintain a consistent low-pressure environment within the container 110. In some embodiments, a low-pressure environment within the container 110 can be configured to help draw fluid into the container 110.


The ultrasonic-sensor data store 150 can be configured to store the volume values, the measured time values from the one-or-more ultrasonic sensors 124, the time-of-day values, the device-status value, the device-operating-condition value, the voided number in the user-defined time-period value or a combination thereof. In some embodiments, the ultrasonic-sensor data store 150 can store the volume values and time-of-day values as the associated pairings of {time-of-day value, volume value}. In some embodiments, the communications logic 148 can be configured to transmit each associated pairing of {time-of-day value, volume value} to a computing device, an electronic medical record (“EMR”) system or the like. The communications logic 148 can be configured to wirelessly transmit the associated pairings of {time-of-day value, volume value} to the computing device. Wireless communication modalities can include Wi-Fi, Bluetooth®, Near Field Communications (NFC), cellular Global System for Mobile Communication (“GSM”), electromagnetic (EM), radio frequency (RF), combinations thereof, or the like.


In some embodiments, the one-or-more accelerometers 122 can be configured to detect acceleration of the container 110 at regular timed intervals (e.g., every five minutes, every hour, every 30 seconds, or the like). In some embodiments, the one-or-more accelerometers 122 can be configured to detect acceleration of the container 110 at user-defined intervals. The automated UO-measuring system 100 can be configured to take a volume value every time the accelerometer value is below the near-zero threshold accelerometer value. In some embodiments, the automated UO-measuring system 100 can be configured to take a volume value when two consecutive accelerometer values are below the near-zero threshold accelerometer value. In some embodiments, the automated UO-measuring system 100 can be configured to take a volume value at either regular timed intervals or the user-defined intervals. In an embodiment, the user can define how many volume values the console 130 generates in a specific time period. For example, the user can desire 8 volume values in 8 hours and the automated UO-measuring system 100 can be configured to detect 1 volume value per hour or the automated UO-measuring system 100 can be configured to continually detect the acceleration state of the container 110 until 1 volume value is obtained within the hour time block.


In an embodiment, the one-or-more accelerometers 122 can be configured to detect accelerometer values of the container 110 at a regular timed interval of once every one hour. In this embodiment, if the one-or-more accelerometers 122 do detect accelerometer values of the container 110 greater than the near-zero threshold accelerometer value during the hour, the one-or-more accelerometers 122 can be configured to either wait until the next hour to detect accelerometer values of the container 110 or can wait a certain amount of time (e.g. 5 minutes) to commence detecting accelerometer values of the container 110.


In some embodiments, the console 130 can be configured to notify the user when the volume value of the volume of voided urine within the container 110 is approaching the maximum allowable volume within the container 110. In some embodiments, the maximum allowable volume can be the maximum allowable volume contained within the container 110 or can be the maximum volume of voided urine the container 110 can hold before the volume of voided urine expands into the proximal section 111 of the container 110. The console 130 can wirelessly send the information to the computing device to notify the user through visual or an audible signal.



FIGS. 3A-3B illustrate methods of measuring urinary output in accordance with some embodiments. In some embodiments, as illustrated in FIG. 3A, the panel 120 including the one-or-more accelerometers 122, the one-or-more ultrasonic sensors 124 and the console 130 can be located at a distal end 114 of the container 110. The panel 120 arranges the one-or-more ultrasonic sensors 124 to be pointing proximally, towards an air/urine interface 160. The one-or-more accelerometers 122 can detect accelerometer values of the container 110 that can then be used by the console 130 to determine the acceleration state of the container 110. In some embodiments, the console 130 can be configured to activate the one-or-more ultrasonic sensors 124 only when the acceleration of the container 110 is below the near-zero threshold accelerometer value. Once the acceleration of the container 110 is below the near-zero threshold accelerometer value, the one-or-more ultrasonic sensors 124 can generate an ultrasonic wave that travels proximally through the urine until the ultrasonic wave reaches the urine/air interface 160. The ultrasonic wave is then reflected distally back through the urine, until the ultrasonic wave reaches the one-or-more ultrasonic sensors 124. The time from generation of the ultrasonic wave to the time a sensor of the one-or-more ultrasonic sensors 124 receives the reflection can be measured and transmitted to the console 130. The console 130 can be configured to send the information to the computing device to correlate the measured time to a volume value that correlates to the volume of voided urine within the container 110. In some embodiments, the console 130 can be configured to send the information to the computing device to correlate the volume value with a time-of-day value, which can be transmitted to a computing device.


As illustrated in FIG. 3B, in some embodiments, the panel 120 can be located at the proximal end 112 of the container 110. The panel 120 arranges the one-or-more ultrasonic sensors 124 to be pointing distally, towards the air/urine interface 160. Once the acceleration of the container 110 is below the near-zero threshold accelerometer value, the console 130 can be configured to activate the one-or-more ultrasonic sensors 124. The one-or-more ultrasonic sensors 124 can generate an ultrasonic wave that travels distally through the air until the ultrasonic wave reaches the air/urine interface 160. The ultrasonic wave is then reflected proximally back through the air, until the ultrasonic wave reaches the one-or-more ultrasonic sensors 124. The time from generation of the ultrasonic wave to the one-or-more ultrasonic sensors 124 receiving the reflection of the ultrasonic wave can be measured and transmitted to the console 130. The console 130 can be configured to correlate the measured time to a volume value of the volume of voided urine in the container 110. The console 130 can also be configured to correlate the volume value with a time-of-day value, which can be transmitted to a computing device.


In an embodiment, the valve 126 can be located at the proximal end 112 of the container 110 and the panel 120 including the one-or-more accelerometers 122 and the one-or-more ultrasonic sensors 124 can be located at the distal end 114 of the container 110. The one-or-more ultrasonic sensors 124 can generate an ultrasonic wave that travels through the volume of voided urine until the wave reaches the urine/air interface 160 where it is reflected back to the one-or-more ultrasonic sensors 124.



FIGS. 4A-4B illustrate a container holder (“holder”) 170 of the automated UO-measuring system 100 in accordance with some embodiments. In some embodiments, the container 110 can be secured to the user's appendage 152 by the holder 170. In some embodiments, the holder 170 can include a sleeve 172 having a pocket 176 configured to securely hold the container 110 therein. As used herein, “securely held” means held so that the container 110 is firmly positioned so as not to become easily displaced to prevent user discomfort. In some embodiments, the sleeve 172 can be constructed of one or more fabrics configured to provide a compressing force on the user's appendage 152 to prevent unwanted movement of the holder 170. In some embodiments, the pocket 176 can be constructed of one or more fabrics configured to provide a compressing force on the container 110 to prevent unwanted movement of the container 110. In some embodiments, the holder 170 can include two or more arms such as the first pair of fastening arms 174A and the first pair of securing arms 174B extending laterally from the sleeve 172. Indeed, as illustrated in FIG. 4A, the holder 170 can include a first pair of fastening arms 174A and a first pair of securing arms 174B. In some embodiments, as illustrated in FIG. 4B, the first pair of fastening arms 174A can be configured to wrap around the user's appendage 152 and be detachably secured to the first pair of securing arms 174B. In some embodiments, the first pair of fastening arms 174A can be detachably coupled to the first pair of securing arms 174B by hook-and-loop fasteners, magnets or the like. In some embodiments, the first pair of fastening arms 174A can include the hook components of the hook-and-loop fasteners and the first pair of securing arms 174B can include the loop components of the hook-and-loop fasteners. In some embodiments, the first pair of fastening arms 174A can include the loop components of the hook-and-loop fasteners and the first pair of securing arms 174B can include the hook components of the hook-and-loop fasteners.



FIGS. 5A-5B illustrate different views of the holder 170 of the automated UO-measuring system 100 in accordance with some other embodiments. In some embodiments, as illustrated in FIG. 5A, the user can couple the container 110 to his or her appendage 152 by using a compression sock 190 having a pouch 192. In some embodiments, the pouch 192 can be configured to slidably receive the container 110 therein. The compression sock 190 can be configured to have the pouch 192 located medially or more offset from a midline. The compression sock 190 and the pouch 192 can be constructed from one or more fabrics that are configured to provide a compressing force on the container 110 to prevent unwanted movement of the container 110. In some embodiments, the pouch 192 has a pouch length 194 and pouch width 196. In some embodiments, the pouch length 194 can be smaller than the container 110, equal to the container 110 or greater than the container 110. Although FIGS. 4A-4B and FIGS. 5A-5B illustrate various embodiments of the holder 170 of the automated UO-measuring system 100, it can be appreciated that other methods of coupling the container 110 to the user's appendage 152 are considered.



FIG. 6 illustrates a flow chart of a method 200 of automatically measuring urinary output using the automated UO-measuring system 100 in accordance with some embodiments. In some embodiments, the method 200 includes capturing voided urine from a user (block 202). In some embodiments, capturing voided urine includes using the automated UO-measuring system 100 including the container 110 configured to collect fluid therein, the container 110 having the console 130 coupled to the one-or-more accelerometers 122 and the one-or-more ultrasonic sensors 124, and having the valve 126 configured to pass fluid therethrough. In some embodiments, the container 110 is a rigid container. The automated UO-measuring system 100 further includes a fluid line 156 coupled to the valve 126. The automated UO-measuring system 100 further includes the holder 170 having the sleeve 172 configured to be coupled or secured to the user or the user's appendage 152, distal of the user's bladder 154, the sleeve 172 having the pocket 176 configured to securely hold the container 110 therein. In some embodiments, securing the container 110 with the container holder 170, distal of the user's bladder 154 allows for fluid flow into the container 110 through passive gravity flow. In some embodiments, capturing voided urine includes using a urine collection device coupled to the fluid line 156 configured to channel urine from the user's bladder 154 to the container 110. In some embodiments, capturing a volume of voided urine includes the container 110 having the pump 128 configured to maintain a low-pressure environment in the container 110. In some embodiments, maintaining a low-pressure environment within the container 110 contributes to passive fluid flow into the container 110.


In some embodiments, the method 200 includes detecting an acceleration state of the container 110 (block 204). In some embodiments, detecting the acceleration of the container 110 includes using the one-or-more accelerometers 122 to obtain accelerometer values of the container 110. In some embodiments, the accelerometer values are transmitted to the console 130 and to the computing device where the acceleration state of the container 110 can be determined by comparing the accelerometer values with the near-zero threshold accelerometer value. In some embodiments, detecting the acceleration state of the container 110 includes detecting accelerometer values at regular time intervals, user-defined intervals or continuously detecting accelerometer values.


In some embodiments, the method 200 further includes measuring the volume of voided urine over time in the container 110 (block 206). In some embodiments, measuring the volume of voided urine over time includes measuring the volume of voided urine when the acceleration state of the container 110 is below the near-zero threshold accelerometer value. In some embodiments, measuring the volume of voided urine over time in the container 110 includes generating one or more ultrasonic waves by the one-or-more ultrasonic sensors 124 that travel through the air in the container 110 until the ultrasonic waves reach the air/urine interface 160. Once reaching the air/water interface 160, the ultrasonic waves are reflected back towards the one-or-more ultrasonic sensors 124. In some embodiments, the one-or-more ultrasonic sensors 124 can generate one or more ultrasonic waves that travel through the urine in the container 110 until the ultrasonic waves reach the urine/air interface 160 where they are reflected back through the urine to the one-or-more ultrasonic sensors 124. The time from generation of the ultrasonic wave to receiving the reflected ultrasonic wave can be measured and transmitted to the console 130.


In some embodiments, the method 200 includes correlating the measured volume of voided urine with a volume value and a time-of-day value (block 208). In some embodiments, correlating the measured volume of voided urine with a volume value includes the console 130 correlating the measured time with the volume value, corresponding to the volume of voided urine within the container 110. In some embodiments, correlating the measured volume of voided urine with a volume value and a time-of-day value includes the console 130 and the computing device correlating the volume value with the time-of-day value. In some embodiments, correlating the measured volume of voided urine with a volume value and a time-of-day value includes generating an associated pairing of {time-of-day value, volume value}. In some embodiments, measuring the volume of voided urine over time includes measuring the volume of voided urine at automatically defined or user-defined time intervals.


In some embodiments, the method 200 includes transmitting the volume value and time-of-day value to a computing device (block 210). In some embodiments, transmitting the volume value and time-of-day value to the computing device includes transmitting the associated pairings of {time-of-day value, volume value}. In some embodiments, transmitting the volume value and time-of-day value to the computing device includes transmitting an associated trio of {device-operating-condition value, time-of-day value, volume value}. In some embodiments, transmitting the volume value and time-of-day value to the computing device includes wirelessly transmitting from the console 130 to the computing device. Wireless communication modalities can include Wi-Fi, Bluetooth®, Near Field Communications (NFC), cellular Global System for Mobile Communication (“GSM”), electromagnetic (EM), radio frequency (RF), combinations thereof, or the like. In some embodiments, transmitting the volume value and time-of-day value to the computing device includes transmitting the volume value and time-of-day value as each is measured or determined. In some embodiments, transmitting the volume value and time-of-day value to a computing device includes transmitting the associated volume value and time-of-day value pairing at the end of a user-defined time interval. In some embodiments, transmitting the associated volume value and time-of-day value pairing at includes transmitting the associated trio of {device-operating-condition value, time-of-day value, volume value} at the end of the user-defined time interval. In some embodiments, transmitting the volume value and the time-of-day value to the computing device includes transmitting the volume value and time-of-day value before the volume of voided urine is disposed out of the container 110.


While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications might appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures can be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.

Claims
  • 1. An automated urinary output (“UO”)-measuring system, comprising: a container configured to collect fluid therein, the container comprising: a console;one or more ultrasonic sensors coupled to the console;one or more accelerometers coupled to the console and;a valve configured to pass fluid therethrough, wherein the valve is configured to be decoupled from the container to dispose of fluid collected within the container;a fluid line coupled to the valve; anda container holder comprising: a sleeve configured to be secured to a user; anda pocket configured to securely hold the container,wherein the console includes one of more processors, a non-transitory storage medium, an energy source, and one or more logic modules configured to: receive accelerometer values from the one or more accelerometers;determine an acceleration state of the container; andactivate the one or more ultrasonic sensors only when the acceleration state of the container is below a threshold; andmeasure a volume of voided urine over time in the container by measuring the volume when the acceleration state of the container is zero.
  • 2. The automated UO-measuring system according to claim 1, wherein the console, the one or more ultrasonic sensors, the one or more accelerometers, and the valve are organized into a panel.
  • 3. The automated UO-measuring system according to claim 2, wherein the panel divides the container into a proximal section and a distal section.
  • 4. The automated UO-measuring system according to claim 3, wherein the panel is located at a proximal end or a distal end of the container.
  • 5. The automated UO-measuring system according to claim 2, wherein the panel includes a pump configured to create a low-pressure environment inside the container.
  • 6. The automated UO-measuring system according to claim 5, wherein the one or more logic modules are configured to: receive ultrasonic sensor values from the one or more ultrasonic sensors;correlate the ultrasonic sensor values with a volume-of-voided-urine value within the container and a time-of-day value for a correlation;determine the volume of voided urine using the ultrasonic sensor values;activate the pump to create and maintain the low-pressure environment inside the container;transmit the correlation to a computing device; ora combination thereof.
  • 7. The automated UO-measuring system according to claim 6, wherein: the pump includes a pressure sensor coupled with the console, andthe one or more logic modules are configured to: receive pressure readings from the pressure sensor, andactivate the pump to create and maintain the low-pressure environment inside the container based on the pressure readings.
  • 8. The automated UO-measuring system according to claim 1, wherein the container holder is configured to be detachably secured to the user.
  • 9. The automated UO-measuring system according to claim 8, wherein the sleeve includes two or more arms configured to wrap around an appendage of the user.
  • 10. The automated UO-measuring system according to claim 9, wherein the two or more arms are organized into a first pair of fastening arms and a first pair of securing arms.
  • 11. The automated UO-measuring system according to claim 9, wherein the container holder is secured to the appendage of the user by hook-and-loop fasteners or magnets.
  • 12. The automated UO-measuring system according to claim 1, wherein the sleeve includes a compression sock configured to be slidably secured to an appendage of the user.
  • 13. The automated UO-measuring system according to claim 1, wherein the container is rigid.
  • 14. The automated UO-measuring system according to claim 1, wherein the valve is configured to pass the fluid therethrough during collection of the fluid within the container.
  • 15. A method of automatically measuring urine output, comprising: capturing a volume of voided urine from a user, in a container using a fluid line, the container being coupled to the user distal a bladder of the user,the container configured to be held in a container holder, the container holder comprising: a sleeve configured to be secured to the user; anda pocket configured to securely hold the container;wherein the container includes: a valve configured to pass fluid therethrough, the valve configured to be decoupled from the container to dispose of fluid collected within the container; anda console coupled to one or more ultrasonic sensors and one or more accelerometers;detecting an acceleration state of the container;measuring the volume of voided urine over time in the container;correlating a measured volume of voided urine with a volume value and a time-of-day value; andtransmitting the volume value and the time-of-day value to a computing device,wherein the console includes one of more processors, a non-transitory storage medium, an energy source, and one or more logic modules configured to: receive accelerometer values from the one or more accelerometers;determine the acceleration state of the container;activate the one or more ultrasonic sensors only when the acceleration state of the container is below a threshold; andwherein measuring the volume of voided urine over time in the container includes measuring the volume when the acceleration state of the container is zero.
  • 16. The method according to claim 15, wherein capturing the volume of voided urine from the user includes maintaining a low-pressure environment in the container with a pump of the container.
  • 17. The method according to claim 15, wherein detecting the acceleration state of the container includes using the one or more accelerometers to detect the acceleration state of the container.
  • 18. The method according to claim 15, wherein measuring the volume of voided urine over time in the container includes using the one or more ultrasonic sensors to measure the volume of voided urine over time.
  • 19. The method according to claim 15, wherein measuring the volume of voided urine over time in the container includes both measuring and recording at evenly spaced time intervals.
  • 20. The method according to claim 19, wherein the evenly spaced time intervals are user-defined.
  • 21. The method according to claim 15, wherein transmitting the volume value and the time-of-day value to the computing device includes wirelessly transmitting the volume value and the time-of-day value to the computing device.
PRIORITY

This application claims the benefit of priority to U.S. Provisional Patent Application No. 63/128,558, filed Dec. 21, 2020, which is incorporated by reference in its entirety into this application.

US Referenced Citations (247)
Number Name Date Kind
3661143 Henkin May 1972 A
3781920 Browne et al. Jan 1974 A
3851650 Darling Dec 1974 A
3919455 Sigdell et al. Nov 1975 A
4276889 Kuntz et al. Jul 1981 A
4286590 Murase Sep 1981 A
4291692 Bowman et al. Sep 1981 A
4296749 Pontifex Oct 1981 A
4305405 Meisch Dec 1981 A
4312352 Meisch et al. Jan 1982 A
4343316 Jespersen Aug 1982 A
4443219 Meisch et al. Apr 1984 A
4448207 Parrish May 1984 A
4509366 Matsushita et al. Apr 1985 A
4532936 LeVeen et al. Aug 1985 A
4658834 Blankenship et al. Apr 1987 A
4712567 Gille et al. Dec 1987 A
4723950 Lee Feb 1988 A
4834706 Beck et al. May 1989 A
4850375 Rosenberg Jul 1989 A
4889532 Metz et al. Dec 1989 A
5002541 Conkling et al. Mar 1991 A
5146637 Bressler et al. Sep 1992 A
5409014 Napoli et al. Apr 1995 A
5586085 Lichte Dec 1996 A
5725515 Propp Mar 1998 A
5733319 Neilson et al. Mar 1998 A
5738656 Wagner Apr 1998 A
5747824 Jung et al. May 1998 A
5769087 Westphal et al. Jun 1998 A
5807278 McRae Sep 1998 A
5823972 McRae Oct 1998 A
5891051 Han et al. Apr 1999 A
5911786 Nielsen et al. Jun 1999 A
6129684 Sippel et al. Oct 2000 A
6132407 Genese et al. Oct 2000 A
6250152 Klein et al. Jun 2001 B1
6256532 Cha Jul 2001 B1
6261254 Baron et al. Jul 2001 B1
6434418 Neal et al. Aug 2002 B1
6579247 Abramovitch et al. Jun 2003 B1
6592612 Samson et al. Jul 2003 B1
6709420 Lincoln et al. Mar 2004 B1
6716200 Bracken et al. Apr 2004 B2
7011634 Paasch et al. Mar 2006 B2
7161484 Tsoukalis Jan 2007 B2
7211037 Briggs et al. May 2007 B2
7437945 Feller Oct 2008 B1
7442754 Tepper et al. Oct 2008 B2
7739907 Boiarski Jun 2010 B2
7871385 Levinson Jan 2011 B2
7931630 Nishtala et al. Apr 2011 B2
7976533 Larsson Jul 2011 B2
7998126 Fernandez Aug 2011 B1
8295933 Gerber et al. Oct 2012 B2
8328733 Forte et al. Dec 2012 B2
8328734 Salvadori et al. Dec 2012 B2
8337476 Greenwald et al. Dec 2012 B2
8374688 Libbus et al. Feb 2013 B2
8403884 Nishtala Mar 2013 B2
8471231 Paz Jun 2013 B2
8663128 Paz et al. Mar 2014 B2
8773259 Judy et al. Jul 2014 B2
8790277 Elliott et al. Jul 2014 B2
8790320 Christensen Jul 2014 B2
8790577 Mizumoto et al. Jul 2014 B2
8813551 Boiarski Aug 2014 B2
8827924 Paz et al. Sep 2014 B2
8832558 Cardarelli et al. Sep 2014 B2
8900196 Andino Dec 2014 B2
9045887 O'Malley Jun 2015 B2
9050046 Elliott et al. Jun 2015 B2
9074920 Mendels et al. Jul 2015 B2
9216242 Nishtala et al. Dec 2015 B2
9480821 Ciccone et al. Nov 2016 B2
9592034 Hall et al. Mar 2017 B2
9642987 Bierman et al. May 2017 B2
9731097 Andino et al. Aug 2017 B2
9895095 Chen Feb 2018 B2
9962516 Lampotang et al. May 2018 B2
10182747 Charlez et al. Jan 2019 B2
10245008 Paige Apr 2019 B2
10362981 Paz et al. Jul 2019 B2
10383606 McCord et al. Aug 2019 B1
10448875 Holt et al. Oct 2019 B2
10799386 Harrison, Sr. Oct 2020 B1
10881778 Scarpaci et al. Jan 2021 B2
11540760 Guillemette Jan 2023 B1
11703365 Tourchak et al. Jul 2023 B2
20010056226 Zodnik et al. Dec 2001 A1
20020016719 Nemeth et al. Feb 2002 A1
20020161314 Sarajarvi Oct 2002 A1
20020193760 Thompson Dec 2002 A1
20030000303 Livingston et al. Jan 2003 A1
20030163183 Carson Aug 2003 A1
20030163287 Vock et al. Aug 2003 A1
20040267086 Anstadt et al. Dec 2004 A1
20050020958 Paolini et al. Jan 2005 A1
20050065583 Voorhees et al. Mar 2005 A1
20050172712 Nyce Aug 2005 A1
20050247121 Pelster Nov 2005 A1
20060065713 Kingery Mar 2006 A1
20060100743 Townsend et al. May 2006 A1
20060253091 Vernon Nov 2006 A1
20070010797 Nishtala et al. Jan 2007 A1
20070106177 Hama May 2007 A1
20070145137 Mrowiec Jun 2007 A1
20070225668 Otto Sep 2007 A1
20070252714 Rondoni et al. Nov 2007 A1
20080217391 Roof et al. Sep 2008 A1
20080312550 Nishtala et al. Dec 2008 A1
20080312556 Dijkman Dec 2008 A1
20090056020 Caminade et al. Mar 2009 A1
20090099629 Carson et al. Apr 2009 A1
20090157430 Rule et al. Jun 2009 A1
20090287170 Otto Nov 2009 A1
20090315684 Sacco et al. Dec 2009 A1
20100064426 Chikara Imamura Mar 2010 A1
20100094204 Nishtala Apr 2010 A1
20100130949 Garcia May 2010 A1
20100137743 Nishtala et al. Jun 2010 A1
20110113540 Plate et al. May 2011 A1
20110120219 Barlesi et al. May 2011 A1
20110178425 Nishtala et al. Jul 2011 A1
20110224636 Keisic Sep 2011 A1
20110230824 Salinas et al. Sep 2011 A1
20110238042 Davis et al. Sep 2011 A1
20110251572 Nishtala et al. Oct 2011 A1
20110263952 Bergman et al. Oct 2011 A1
20120029408 Beaudin Feb 2012 A1
20120035496 Denison et al. Feb 2012 A1
20120059286 Hastings et al. Mar 2012 A1
20120078137 Mendels et al. Mar 2012 A1
20120078235 Martin et al. Mar 2012 A1
20120095304 Biondi Apr 2012 A1
20120109008 Charlez et al. May 2012 A1
20120118650 Gill May 2012 A1
20120123233 Cohen May 2012 A1
20120127103 Qualey et al. May 2012 A1
20120226196 DiMino et al. Sep 2012 A1
20120234434 Woodruff et al. Sep 2012 A1
20120302917 Fitzgerald et al. Nov 2012 A1
20120323144 Coston et al. Dec 2012 A1
20120323502 Tanoura et al. Dec 2012 A1
20130066166 Burnett et al. Mar 2013 A1
20130109927 Menzel May 2013 A1
20130109928 Menzel May 2013 A1
20130131610 Dewaele et al. May 2013 A1
20130218106 Coston et al. Aug 2013 A1
20130245498 Delaney et al. Sep 2013 A1
20130267871 Delaney et al. Oct 2013 A1
20140039348 Bullington et al. Feb 2014 A1
20140155781 Bullington et al. Jun 2014 A1
20140155782 Bullington et al. Jun 2014 A1
20140159921 Qualey et al. Jun 2014 A1
20140187666 Aizenberg et al. Jul 2014 A1
20140207085 Brandt et al. Jul 2014 A1
20140243635 Arefieg Aug 2014 A1
20140335490 Baarman et al. Nov 2014 A1
20150120321 David et al. Apr 2015 A1
20150233749 Wang et al. Aug 2015 A1
20150342576 Hall et al. Dec 2015 A1
20150343173 Tobescu et al. Dec 2015 A1
20150359522 Recht et al. Dec 2015 A1
20150362351 Joshi et al. Dec 2015 A1
20160051176 Ramos et al. Feb 2016 A1
20160183819 Burnett et al. Jun 2016 A1
20170035342 Elia et al. Feb 2017 A1
20170043089 Handler Feb 2017 A1
20170100068 Kostov Apr 2017 A1
20170113000 Tobescu et al. Apr 2017 A1
20170136209 Burnett May 2017 A1
20170140103 Angelides May 2017 A1
20170196478 Hunter Jul 2017 A1
20170202698 Zani et al. Jul 2017 A1
20170249445 Devries et al. Aug 2017 A1
20170290540 Franco Oct 2017 A1
20170291012 Iglesias Oct 2017 A1
20170307423 Pahwa et al. Oct 2017 A1
20170322197 Hall et al. Nov 2017 A1
20180015251 Lampotang et al. Jan 2018 A1
20180110456 Cooper et al. Apr 2018 A1
20180160961 Gopinathan et al. Jun 2018 A1
20180214122 Ansell et al. Aug 2018 A1
20180214297 Hughett et al. Aug 2018 A1
20180245967 Parker et al. Aug 2018 A1
20180280236 Ludin et al. Oct 2018 A1
20180317891 Kim Nov 2018 A1
20180344234 McKinney et al. Dec 2018 A1
20190006047 Gorek et al. Jan 2019 A1
20190017535 Ormsbee et al. Jan 2019 A1
20190046102 Kushnir et al. Feb 2019 A1
20190069829 Bulut Mar 2019 A1
20190069830 Holt et al. Mar 2019 A1
20190126006 Rehm et al. May 2019 A1
20190150821 Waters et al. May 2019 A1
20190167144 Jung et al. Jun 2019 A1
20190201596 Luxon et al. Jul 2019 A1
20190223844 Aboagye et al. Jul 2019 A1
20190247236 Sides et al. Aug 2019 A1
20190254582 Wei et al. Aug 2019 A1
20190321588 Burnett et al. Oct 2019 A1
20190328945 Analytis et al. Oct 2019 A1
20190358387 Elbadry et al. Nov 2019 A1
20190365308 Laing et al. Dec 2019 A1
20190381223 Culbert et al. Dec 2019 A1
20200022637 Kurzrock et al. Jan 2020 A1
20200064172 Tabaczewski et al. Feb 2020 A1
20200085378 Burnett et al. Mar 2020 A1
20200187863 Tu et al. Jun 2020 A1
20200268302 Oh Aug 2020 A1
20200268303 Oliva Aug 2020 A1
20200289749 Odashima et al. Sep 2020 A1
20200405524 Gill Dec 2020 A1
20210054610 Hall et al. Feb 2021 A1
20210077007 Jouret et al. Mar 2021 A1
20210100533 Seres et al. Apr 2021 A1
20210299353 Mannu Sep 2021 A1
20220018692 Tourchak et al. Jan 2022 A1
20220026001 Cheng et al. Jan 2022 A1
20220026261 Funnell et al. Jan 2022 A1
20220079487 Horiguchi et al. Mar 2022 A1
20220192564 Kriscovich et al. Jun 2022 A1
20220192565 Cheng et al. Jun 2022 A1
20220193375 Rehm et al. Jun 2022 A1
20220233120 Beuret Jul 2022 A1
20220296140 Nguyen et al. Sep 2022 A1
20220330867 Conley et al. Oct 2022 A1
20220386917 Mann et al. Dec 2022 A1
20230019703 Behzad et al. Jan 2023 A1
20230022547 Cho et al. Jan 2023 A1
20230025333 Patel et al. Jan 2023 A1
20230028966 Franano Jan 2023 A1
20230035669 Raja et al. Feb 2023 A1
20230040915 Compton et al. Feb 2023 A1
20230058553 Fallows et al. Feb 2023 A1
20230060232 Patel et al. Mar 2023 A1
20230084476 Robichaud et al. Mar 2023 A1
20240042120 Cheng et al. Feb 2024 A1
20240081708 Kelly et al. Mar 2024 A1
20240108268 Woodard et al. Apr 2024 A1
20240252783 Waitkus et al. Aug 2024 A1
20240347162 Meese et al. Oct 2024 A1
20240360938 Cheng et al. Oct 2024 A1
20240424186 Justice et al. Dec 2024 A1
20250090066 Tourchak Mar 2025 A1
20250120636 Compton et al. Apr 2025 A1
Foreign Referenced Citations (59)
Number Date Country
2882654 Oct 2007 CA
2445749 Sep 2001 CN
200951235 Sep 2007 CN
201492414 Jun 2010 CN
102647939 Aug 2012 CN
103054559 May 2015 CN
107952140 Apr 2018 CN
109498013 Mar 2019 CN
110859636 Mar 2020 CN
112426156 Mar 2021 CN
0342028 Nov 1989 EP
2760470 May 2020 ES
2437549 Oct 2007 GB
2576743 Mar 2020 GB
S49-75171 Jul 1974 JP
S54-147066 Nov 1979 JP
S58-190719 Nov 1983 JP
S60-219517 Nov 1985 JP
H02-057240 Dec 1990 JP
H08-271301 Oct 1996 JP
H10-104041 Apr 1998 JP
2007-303982 Nov 2007 JP
2008-524618 Jul 2008 JP
2009-068959 Apr 2009 JP
2010-121950 Jun 2010 JP
2010-530978 Sep 2010 JP
2012-105947 Jun 2012 JP
2012-225790 Nov 2012 JP
2018108356 Jul 2018 JP
20070115495 Dec 2007 KR
2013740 Aug 2016 NL
2615727 Apr 2017 RU
1981003427 Dec 1981 WO
2004045410 Jun 2004 WO
2013013782 Jan 2013 WO
20130178742 Dec 2013 WO
2014043650 Mar 2014 WO
2014105755 Jul 2014 WO
2014108690 Jul 2014 WO
2014135856 Sep 2014 WO
2014151068 Sep 2014 WO
2014145971 Sep 2014 WO
201511402 Jan 2015 WO
2015105916 Jul 2015 WO
2015127390 Aug 2015 WO
2015191125 Dec 2015 WO
2016177901 Nov 2016 WO
2017023794 Feb 2017 WO
2018156624 Aug 2018 WO
2019066357 Apr 2019 WO
2019106675 Jun 2019 WO
2019226697 Nov 2019 WO
2020033752 Feb 2020 WO
2020154370 Jul 2020 WO
2022108589 May 2022 WO
2022182794 Sep 2022 WO
2023022895 Feb 2023 WO
2023027871 Mar 2023 WO
2023076067 May 2023 WO
Non-Patent Literature Citations (73)
Entry
“Urocare Reusable Night Drain Bottle—Urinary Collection System” Aug. 13, 2020, HealthProductsForYou.com, <https://www.healthproductsforyou.com/p-urocare-reusable-night-drain-bottle-urinary-collection-system.html> retrieved from Archive.org (Year: 2020).
English translation of Danilov (RU 2615727 C2) (Year: 2017).
U.S. Appl. No. 15/748,107, filed Jan. 26, 2018 Notice of Allowance dated Dec. 12, 2022.
U.S. Appl. No. 17/054,493, filed Nov. 10, 2020 Non-Final Office Action dated Jan. 27, 2023.
U.S. Appl. No. 17/3026,821, filed May 3, 2021 Non-Final Office Action dated Jan. 10, 2023.
U.S. Appl. No. 17/373,535, filed Jul. 12, 2021 Non-Final Office Action dated Nov. 9, 2022.
Bard Medical, Criticore Disposables—Non I.C., 3 pages, www.bardmedical.com/products/patienl-moniloring-,ystems/criticore®-system/criticore®-disposables-non-ic/ Jan. 30, 2015.
Bard Medical, Criticore Infection Control Disposables, 3 pages, www.bardmedical.com/patienl-monitoring-,ystems/criticore®-system/criticore®-infection-control-disposables/ Jan. 30, 2015.
Bard Medical, Criticore Monitor, 11 pages, www.bardmedical.com/products/patient-monitoring-systems/criticore®-monitor/ Jan. 30, 2015.
Bard Medical, Urine Meiers, 3 pages, www.bardmedical.com/producls/urological-drainage/urine-collection/urinemeters/Jan. 30, 2015.
Biometrix, Urimetrix, 4 pages, www.biometrixmedical.com/Products/56/Urimetrix%E2%84%A2 Oct. 29, 2014.
Observe Medical, sippi, 3 pages, www.observemedical.com/products.html Oct. 29, 2014.
PCT/US19/33389 filed May 21, 2019 International Search Report and Written Opinion dated Aug. 2, 2019.
PCT/US2016/044835 filed Jul. 20, 2016 International Search Report and Written Opinion dated Dec. 16, 2016.
U.S. Appl. No. 17/054,493, filed Nov. 10, 2020 Final Office Action dated May 31, 2022.
U.S. Appl. No. 15/748,107, filed Jan. 26, 2018 Final Office Action dated Dec. 23, 2020.
U.S. Appl. No. 15/748,107, filed Jan. 26, 2018 Final Office Action dated Feb. 7, 2022.
U.S. Appl. No. 15/748,107, filed Jan. 26, 2018 Non-Final Office Action dated Sep. 3, 2021.
U.S. Appl. No. 15/748,107, filed Jan. 26, 2018 Non-Final Office Action dated Sep. 4, 2020.
U.S. Appl. No. 17/054,493, filed Nov. 10, 2020 Non-Final Office Action dated Nov. 24, 2021.
PCT/US2022/017574 filed Feb. 23, 2022 Internation Search Report and Written Opinion dated Jun. 8, 2022.
Schlebusch, T. et al., “Bladder volume estimation from electrical impedance tomography” Physiological Measurement Institute of Physics Publishing, Bristol, GB. vol. 35 No. 9 Aug. 20, 2014. (Aug. 20, 2014).
U.S. Appl. No. 17/306,821, filed May 3, 2021 Final Office Action dated Jul. 19, 2023.
U.S. Appl. No. 17/556,907, filed Dec. 20, 2021 Non-Final Office Action dated Aug. 17, 2023.
PCT/US2019/045787 filed Aug. 8, 2019 International Preliminary Report on Patentability dated Feb. 16, 2021.
PCT/US2019/045787 filed Aug. 8, 2019 International Search Report and Written Opinion dated Oct. 2, 2019.
DFree Personal—Consumer Product Brochure, 2019.
DFree Pro Brochure 2019.
Leonhäuser, D et al., “Evaluation of electrical impedance tomography for determination of urinary bladder volume: comparison with standard ultrasound methods in healthy volunteers.”—BioMed Engr On-line; 17:95; 2018.
Li, R., et al., “Design of a Noninvasive Bladder Urinary Volume Monitoring System Based on Bio-Impedance.”—Engineering; vol. 5; pp. 321-325; 2013.
Reichmuth, M., et al., “A Non-invasive Wearable Bioimpedance System to Wirelessly Monitor Bladder Filling.”—Dep. of Health Sciences and Technology—Department of Information Technology and Electrical Engineering ETH Zurich, Zurich, Switzerland—Conference Paper; Mar. 2020.
SECA product catalog, https://us.secashop.com/products/seca-mbca/seca-mbca-514/5141321139, last accessed Sep. 11, 2020.
U.S. Appl. No. 17/054,493, filed Nov. 10, 2020 Final Office Action dated Oct. 4, 2023.
U.S. Appl. No. 17/262,080, filed Jan. 21, 2021 Final Office Action dated Sep. 11, 2023.
U.S. Appl. No. 17/262,080, filed Jan. 21, 2021 Notice of Allowance dated Oct. 13, 2023.
U.S. Appl. No. 17/306,821, filed May 3, 2021 Advisory Action dated Oct. 3, 2023.
U.S. Appl. No. 17/373,546, filed Jul. 12, 2021 Non-Final Office Action dated Nov. 1, 2023.
EP 23188337.2 filed May 21, 2019 Extended European Search Report dated Dec. 4, 2023.
PCT/US2019/033389 filed Nov. 26, 2020 Extended European Search Report dated Jun. 4, 2021.
U.S. Appl. No. 17/054,493, filed Nov. 10, 2020 Notice of Allowance dated Jan. 4, 2024.
U.S. Appl. No. 17/556,907, filed Dec. 20, 2021 Notice of Allowance dated Dec. 6, 2023.
PCT/US20/61367 filed Nov. 19, 2020 International Search Report and Written Opinion dated Feb. 22, 2021.
U.S. Appl. No. 17/262,080, filed Jan. 21, 2021 Non-Final Office Action dated Apr. 6, 2023.
U.S. Appl. No. 17/373,535, filed Jul. 12, 2021 Notice of Allowance dated Feb. 23, 2023.
U.S. Appl. No. 17/556,907, filed Dec. 20, 2021 Restriction Requirement dated May 12, 2023.
EP 20962628.2 filed May 31, 2023 Extended European Search Report dated Apr. 20, 2024.
PCT/US2022/039191 filed Aug. 2, 2022 International Search Report and Written Opinion dated Dec. 5, 2022.
PCT/US2022/039746 filed Aug. 8, 2022 International Search Report and Written Opinion dated Nov. 18, 2022.
U.S. Appl. No. 17/306,821, filed May 3, 2021 Notice of Allowance dated Apr. 23, 2024.
U.S. Appl. No. 17/373,546, filed Jul. 12, 2021 Notice of Allowance dated Mar. 7, 2024.
U.S. Appl. No. 17/373,546, filed Jul. 12, 2021 Notice of Allowance dated May 29, 2024.
U.S. Appl. No. 17/552,250, filed Dec. 15, 2021 Non-Final Office Action dated Sep. 19, 2024.
PCT/US2022/046920 filed Oct. 17, 2022 International Search Report and Written Opinion dated Feb. 20, 2023.
U.S. Appl. No. 17/560,079, filed Dec. 22, 2021 Notice of Allowance dated Oct. 29, 2024.
“Volumetric Flow Rate”, www.vcalc.com/wiki/JeffNolumetric+%28Fluid%29+Flow+Rate, accessed Jan. 9, 2025, created Mar. 8, 2018 (Year: 2018).
U.S. Appl. No. 17/552,250, filed Dec. 15, 2021 Final Office Action dated Feb. 11, 2025.
U.S. Appl. No. 17/587,938, filed Jan. 28, 2022 Restriction Requirement dated Jan. 22, 2025.
U.S. Appl. No. 17/833,682, filed Jun. 6, 2022 Non-Final Office Action dated Jan. 15, 2025.
U.S. Appl. No. 17/870,698, filed Jul. 21, 2022 Restriction Requirement dated Feb. 12, 2025.
U.S. Appl. No. 17/879,658, filed Aug. 2, 2022 Non-Final Office Action dated Dec. 30, 2024.
U.S. Appl. No. 17/893,435, filed Aug. 23, 2022 Non-Final Office Action dated Jan. 17, 2025.
U.S. Appl. No. 17/552,250, filed Dec. 15, 2021 Advisory Action dated May 8, 2025.
U.S. Appl. No. 17/552,250, filed Dec. 15, 2021 Notice of Allowance dated May 20, 2025.
U.S. Appl. No. 17/587,938, filed Jan. 28, 2022 Non-Final Office Action dated May 12, 2025.
U.S. Appl. No. 17/682,785, filed Feb. 28, 2022 Restriction Requirement dated Apr. 2, 2025.
U.S. Appl. No. 17/833,682, filed Jun. 6, 2022 Final Office Action dated May 12, 2025.
U.S. Appl. No. 17/863,223, filed Jul. 12, 2022 Non-Final Office Action dated Apr. 2, 2025.
U.S. Appl. No. 17/863,923, filed Jul. 13, 2022 Restriction Requirement dated May 21, 2025.
U.S. Appl. No. 17/870,698, filed Jul. 21, 2022 Non-Final Office Action dated Apr. 9, 2025.
U.S. Appl. No. 17/873,834, filed Jul. 26, 2022 Non-Final Office Action dated May 19, 2025.
U.S. Appl. No. 17/879,658, filed Aug. 2, 2022 Final Office Action dated May 14, 2025.
U.S. Appl. No. 17/883,507, filed Aug. 8, 2022 Restriction Requirement dated May 19, 2025.
U.S. Appl. No. 18/278,167 filed Aug. 21, 2023 Non-Final Office Action dated Apr. 24, 2025.
Related Publications (1)
Number Date Country
20220192566 A1 Jun 2022 US
Provisional Applications (1)
Number Date Country
63128558 Dec 2020 US